Patent: 10,934,341
✉ Email this page to a colleague
Summary for Patent: 10,934,341
| Title: | Albumin variants |
| Abstract: | The present invention relates to variants of a parent albumin, the variants having altered plasma half-life compared with the parent albumin. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants. |
| Inventor(s): | Jason Cameron, Karen Ann Delahay, Jens Erik Nielsen, Andrew Plumridge, Jan Terje Andersen |
| Assignee: | Sartorius Albumedix Ltd , Novozymes Biopharma DK AS |
| Application Number: | US16/598,939 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,934,341
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Kedrion, S.p.a. | KEDBUMIN | albumin (human) | Injection | 125384 | June 03, 2011 | 10,934,341 | 2039-10-10 |
| Kedrion Biopharma Inc. | KEDBUMIN | albumin (human) | Injection | 125384 | 3-Jun-11 | 10,934,341 | 2039-10-10 |
| Kedrion, S.p.a. | KEDBUMIN | albumin (human) | Injection | 125384 | September 05, 2013 | 10,934,341 | 2039-10-10 |
| Kedrion Biopharma Inc. | KEDBUMIN | albumin (human) | Injection | 125384 | 5-Sep-13 | 10,934,341 | 2039-10-10 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 10,934,341
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2013343503 | ⤷ Start Trial |
| Australia | 2018201136 | ⤷ Start Trial |
| Brazil | 112015010318 | ⤷ Start Trial |
| Canada | 2890766 | ⤷ Start Trial |
| China | 105452290 | ⤷ Start Trial |
| European Patent Office | 2917233 | ⤷ Start Trial |
| United Kingdom | 201319754 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
